
China urges firms to make generic versions of 34 drugs
pharmafile | June 25, 2019 | News story | Research and Development | China, NHC, generic drugs, generics, patents, pharma
China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not currently available as generics.
China’s NHC has published a list of 34 patented drugs which it hopes will be taken up by generic drugmakers.
The drugs selected include drugs whose patents have expired, drugs whose patents are close to expiry, drugs that are in short supply and drugs whose manufacturers have voluntarily applied.
The list includes drugs to treat life threatening conditions including AIDS and leukaemia. From now on, similar lists will be published every year.
The list comes after the State Council released guidelines calling on the authorities to take measures to boost the production of generic drugs that are in short supply. It is hoped that generic drugs will prevent shortages and reduce expenditure.
Louis Goss
Related Content

Pharma sees climate disruption as growing supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …





